NN-390 是一种有效的选择性 HDAC6 抑制剂(IC50 为 9.8 nM),可穿透血脑屏障,并在转移性第 3 组成神经管细胞瘤中显示出研究潜力。
产品编号: MS-Y12187 CAS No.: 2490284-25-6 分子式: C17H16F4N2O4S 分子量: 420.38
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价

产品描述

NN-390 是一种有效的选择性 HDAC6 抑制剂(IC50 为 9.8 nM),可穿透血脑屏障,并在转移性第 3 组成神经管细胞瘤中显示出研究潜力。

生物实验数据

生物活性 NN-390 is a potent and selective HDAC6 inhibitor with an IC50 of 9.8 nM that can cross the blood-brain barrier and has shown research potential in metastatic Group 3 medulloblastoma.
IC50 & Target HDAC6:9.8 nM, HDAC2:>5 μM, HDAC1:>5 μM, HDAC8:>1 μM, HDAC11:>1 μM, HDAC3:>1 μM
体外研究
(In Vitro)

NN-390 exhibits cellular potency with IC50 values of 1.19 μM in MV4-11 cells and 1.38 μM in MM.1S cells while having minimal effects on noncancerous counterparts (IC50 > 50 μM in MRC-9).
NN-390 (72 h) strongly decreases proliferation in HD-MB03 cells, with an IC50 of 0.13 μM, and significantly impairs self-renewal of BTIC-enriched HD-MB03s.
NN-390 (0-2 μM, 1 h) markedly increases acetylation of α-tubulin and minimally changes acetylated histone H3.
NN-390 (6 h) results in acetylation of α-tubulin from concentrations as low as 0.1 μM (0-0.2 μM), and dose-dependent increases in acetylation of α-tubulin (0-0.2 μM).
NN-390 (0-2 μM, 24 h) promotes cancer cells apoptosis in MV4-11 cells.

Immunofluorescence

Cell Line: HeLa cells
Concentration: 0, 0.1, 0.25, 1, 2 μM
Incubation Time: 1 h
Result: Markedly increased acetylation of α-tubulin and minimally changed acetylated histone H3.

Western Blot Analysis

Cell Line: AML (MV4-11) cells
Concentration: 0, 0.1, 0.5, 1, 5 μM
Incubation Time: 6 h
Result: Resulted in acetylation of α-tubulin from concentrations as low as 0.1 μM and with limited acetylation of histone H3 at only the highest concentration of 5 μM.

Western Blot Analysis

Cell Line: Group 3 MB (HD-MB03) cells
Concentration: 0, 0.053, 0.106, 0.158, 0.211 μM
Incubation Time: 6 h
Result: Dose-dependent increased in acetylation of α-tubulin from the lowest concentration of 53 nM, with no observable change in acetylation of off-target histone H3 up to 211 nM.

Apoptosis Analysis

Cell Line: MV4-11 cells
Concentration: 0, 0.25, 0.75, 1, 2 μM
Incubation Time: 24 h
Result: Promoted cancer cells apoptosis, 39% of cancer cells were undergoing late-stage apoptosis after 18 h at 2 μM, and 11% of cells were in the late apoptosis stage at 0.25 μM.
体内研究
(In Vivo)

NN-390 (male CD-1 mice, 20 mg/kg, IP, single dose) increases plasma stability.
NN-390 can improve PAMPA (parallel artificial membrane permeability assay)-BBB (blood-brain barrier) score.
Pharmacokinetic Parameters of NN-390 in male male CD-1 mice.

Compound KT-531 5a; NN-390
t1/2 (h) 1.05 1.90
Cmax (ng/mL) 493 750
AUClast (h*ng/mL) 1576 2523
AUClnf (h*ng/mL) 1519 2548
AUC/D (h*ng/mL) 79 126

Animal Model: CD-1 mice (male, n=3)
Dosage: 20 mg/kg
Administration: IP, single dose (Pharmacokinetic Analysis)
Result: Had a half-life of 115 min in human plasma, a 2.8-fold increase in stability.

化学信息

分子量 420.38
分子式 C17H16F4N2O4S
CAS No. 2490284-25-6

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础